Nagendran Sukumar bought TSHA
December 1, 2025 · Form 4 insider transaction
Nagendran Sukumar bought 260,047 shares of Taysha Gene Therapies, Inc. at $1.71 per share, a transaction worth $444.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
260,047
Price
$1.71
Total value
$444.7K
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 1, 2025
Filing dateDecember 1, 2025
Shares owned after1,266,486
OwnershipDirect
10b5-1 planNo
AmendedNo